CND Life Sciences, Inc.CL
SEC Form D filing

CND Life Sciences, Inc.

Biotech · Series A · Regulation D 506(b) · AZ · Filed June 16, 2026

Offering amount
$6.3M
Exemption
Reg D 506(b)
Issuer state
AZ
Filing date
June 16, 2026
Signature date
June 16, 2026
CIK
0001841099

Summary

Auto-generated

life sciences and diagnostics company, $6.25M series-a in AZ

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.